Testing antigens against COVID 19 | Pandemic PACT Tracker

Key facts

Disease
COVID-19
Start & end year
2020
2021
Known Financial Commitments (USD)
$5,842.48
Funder
Callaghan Innovation
Research Location
New Zealand
Lead Research Institution
Ruakura Technologies Limited
Research Priority Alignment
N/A

Research Category
Pathogen: natural history, transmission and diagnostics
Research Subcategory
Immunity
Special Interest Tags
N/A
Study Type
Unspecified
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Not Applicable
Vulnerable Population
Not applicable
Occupations of Interest
Not applicable

Abstract